New avenues for the treatment of Huntington's disease
A Kim, K Lalonde, A Truesdell, P Gomes Welter… - International journal of …, 2021 - mdpi.com
Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG expansion in
the HD gene. The disease is characterized by neurodegeneration, particularly in the striatum …
the HD gene. The disease is characterized by neurodegeneration, particularly in the striatum …
[HTML][HTML] Targeting mitochondrial network disorganization is protective in C. elegans models of Huntington's disease
Huntington's disease (HD) is an adult-onset neurodegenerative disease caused by a
trinucleotide CAG repeat expansion in the HTT gene. While the pathogenesis of HD is …
trinucleotide CAG repeat expansion in the HTT gene. While the pathogenesis of HD is …
Progression of basal ganglia pathology in heterozygous Q175 knock‐in Huntington's disease mice
Y Deng, H Wang, M Joni, R Sekhri… - Journal of Comparative …, 2021 - Wiley Online Library
We used behavioral testing and morphological methods to detail the progression of basal
ganglia neuron type‐specific pathology and the deficits stemming from them in male …
ganglia neuron type‐specific pathology and the deficits stemming from them in male …
Age-related mitochondrial alterations in brain and skeletal muscle of the YAC128 model of Huntington disease
K Bečanović, M Asghar, I Gadawska… - npj Aging and …, 2021 - nature.com
Mitochondrial dysfunction and bioenergetics failure are common pathological hallmarks in
Huntington's disease (HD) and aging. In the present study, we used the YAC128 murine …
Huntington's disease (HD) and aging. In the present study, we used the YAC128 murine …
AAV vectors for retinal and CNS gene therapy
A Scaria, J Sullivan - US Patent 10,982,228, 2021 - Google Patents
2022-01-07 First worldwide family litigation filed litigation Critical https://patents. darts-ip.
com/? family= 53189202&utm_source= google_patent&utm_medium …
com/? family= 53189202&utm_source= google_patent&utm_medium …
Modulation of SETDB1 activity by APQ ameliorates heterochromatin condensation, motor function, and neuropathology in a Huntington's disease mouse model
YJ Hwang, SJ Hyeon, Y Kim, S Lim… - Journal of enzyme …, 2021 - Taylor & Francis
The present study describes evaluation of epigenetic regulation by a small molecule as the
therapeutic potential for treatment of Huntington's disease (HD). We identified 5-allyloxy-2 …
therapeutic potential for treatment of Huntington's disease (HD). We identified 5-allyloxy-2 …
C57BL/6 background attenuates mHTT toxicity in the striatum of YAC128 mice
MK Back, J Kurzawa, S Ruggieri… - International Journal of …, 2021 - mdpi.com
Mouse models are frequently used to study Huntington's disease (HD). The onset and
severity of neuronal and behavioral pathologies vary greatly between HD mouse models …
severity of neuronal and behavioral pathologies vary greatly between HD mouse models …
Study of vesicular glycolysis in health and Huntington's Disease
M Mc Cluskey - 2021 - theses.hal.science
The axon enables long distance travel of electrical and chemical information between
neurons, a process at the basis of neuronal communication and brain function. This …
neurons, a process at the basis of neuronal communication and brain function. This …
[PDF][PDF] Research Article Differential Changes in Postsynaptic Density Proteins in Postmortem Huntington's Disease and Parkinson's Disease Human Brains
C Fourie, E Kim, H Waldvogel, JM Wong, A McGregor… - academia.edu
NMDA and AMPA-type glutamate receptors and their bound membrane-associated
guanylate kinases (MAGUKs) are critical for synapse development and plasticity. We …
guanylate kinases (MAGUKs) are critical for synapse development and plasticity. We …
Effects of GluN3A silencing in Huntington's disease and systematic mapping of its expression in the mouse forebrain
Á Murillo Bartolomé - 2021 - dspace.umh.es
Effects of GluN3A silencing in Huntington's disease and systematic mapping of its expression in
the mouse forebrain Page 1 Effects of GluN3A silencing in Huntington's disease and systematic …
the mouse forebrain Page 1 Effects of GluN3A silencing in Huntington's disease and systematic …